News for DBV Technologies SA Sponsored ADR Stock (DBVT)

DBV Technologies Announces Appointment of Pascal Wotling as Chief Technical Operations Officer

GlobeNewsWire • 02/06/20

DBV Technologies Announces Closing of Global Offering

GlobeNewsWire • 02/04/20

DBV Technologies Announces Pricing of $153.7 million (€139.8 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares

GlobeNewsWire • 01/30/20

DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares, and Reports December 31, 2019 Cash Position

GlobeNewsWire • 01/29/20

Monthly information regarding the total number of voting rights and total number of shares of the Company

GlobeNewsWire • 01/14/20

DBV Technologies is in Overbought Territory: What???s Next?

Zacks Investment Research • 01/10/20

Here's Why DBV Technologies Shares Jumped Higher Today

The Motley Fool • 01/09/20

Why This Peanut Allergy Study Was Worth the Wait

24/7 Wall Street • 01/09/20

DBV Technologies Reports Positive Three-Year, Long-Term Data from the PEOPLE Phase III Open-Label Extension Study of Viaskin Peanut in Children with Peanut Allergy

GlobeNewsWire • 01/08/20

DBV Technologies Announces Appointment of Ramzi Benamar as Chief Financial Officer

GlobeNewsWire • 01/02/20

DBV Technologies: Selloff Provides Attractive Entry, Big Upside Ahead Of Expected Drug Approval

Seeking Alpha • 12/26/19

Monthly information regarding the total number of voting rights and total number of shares of the Company

GlobeNewsWire • 11/19/19

DBV Technologies to Present at the Stifel 2019 Healthcare Conference

GlobeNewsWire • 11/05/19

DBV Technologies to Highlight the Burden of Peanut Allergy and Patient Experiences with Viaskin Peanut at ACAAI 2019

GlobeNewsWire • 10/24/19

DBV Technologies Announces Closing of Global Offering

GlobeNewsWire • 10/15/19

DBV Technologies Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Connection With its Global Offering of Ordinary Shares in the Form of American Depositary Shares (ADSs)

GlobeNewsWire • 10/10/19

Mise à disposition d’un prospectus dans le cadre de l’admission d’actions nouvelles sur Euronext Paris

GlobeNewsWire • 10/09/19

DBV Technologies Announces Pricing of $125 million (€114 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares

GlobeNewsWire • 10/09/19

DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares, and Reports September 30, 2019 Cash Position

GlobeNewsWire • 10/08/19

Major Step Forward in Peanut Allergy Treatment

24/7 Wall Street • 10/07/19

DBV Technologies Announces FDA Acceptance of BLA filing for Viaskin Peanut for the Treatment of Peanut Allergy

GlobeNewsWire • 10/04/19

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

GlobeNewsWire • 09/19/19

Revolutionary Peanut Allergy Treatment Is One Step Closer

24/7 Wall Street • 08/08/19

DBV Resubmits Regulatory Application For Peanut Allergy Drug, Stock Rallies

Benzinga • 08/08/19

DBV Technologies S.A. (DBVT) Moves to Buy: Rationale Behind the Upgrade

Zacks Investment Research • 06/12/19